Cancer Clinical Trial
Official title:
Northern Sweden Health and Disease Study
NSHDS (Northern Sweden Health and Disease Study) is an umbrella term for a prospective biobank with related survey data. The sample collection consists of three subcohorts, Västerbotten Intervention Programme (VIP), Mammography Screening Project (MA) and MONICA (MONItoring of Trends and Determinants in CArdiovascular Disease). The blood samples are stored at the Northern Sweden Biobank.
The overall aim of the NSHDS is to support frontline research with particular emphasis on
improving diagnostic tools for clinical use, as well as finding early markers of disease,
using the blood samples, tissue and associated health data from the NSHDS. Furthermore, basic
research regarding risk factors as well as pathogenetic pathways are promoted.
The prospective blood samples and related survey data can be linked to national registries
for health outcomes such as cancer diagnosis for which there is a near 100% completeness of
the data.
VIP - VÄSTERBOTTEN INTERVENTION PROGRAMME The VIP is a long-term project intended for health
promotion of the population of the county of Västerbotten (approximately 254,000
inhabitants). All individuals 40, 50, and 60 years of age in the county are invited for
screening. They are asked to complete a questionnaire concerning various lifestyle factors,
including diet, and to donate a blood sample to be frozen for later research purposes. The
cohort is population-based and the inclusion of individuals started 1985 and is ongoing. The
participation rate has ranged between 48 and 67% of the population. But a large number has
not been invited for screening. Among those invited the participation rate has been very
high. The material is population based.
The blood samples consist primarily of EDTA (ethylenediaminetetraacetic acid) and heparin
blood samples divided into plasma, erythrocyte concentrate and buffy coat. Questionnaire data
are linked to blood samples.
The majority of samples are fasting samples. Number of individuals: 103,100 Individuals with
repeated samples: 43,500 Sampling occasions: 151,200 (October 2016)
MA - MAMMOGRAPHY SCREENING PROJECT
Samples and data are collected in connection with mammography screenings 1995-2006. The blood
samples consist primarily of EDTA and heparin blood samples divided into plasma, erythrocyte
concentrate and buffy coat, and for a certain percentage, the DNA is also extracted. The
cohort consists of women, 18-82 years old (95% between 48 and 70 years old).
Survey data can be linked to the blood samples.
Individuals: 28,800 Individuals with repeated samples: 14,600 Sampling occasions: 54,000
THE MONICA STUDY
The MONICA study is a longitudinal population-based database for research in cardiovascular
disease and diabetes. Since 1985, seven screenings has been performed (1986, 1990, 1994,
1999, 2004, 2009 and 2014) of a randomized selection of the population in the counties of
Västerbotten and Norrbotten in Northern Sweden.
Individuals: 11,800 Individuals with repeated samples: 3,500 Sampling occasions: 15,300
This registration will only cover blood sampling (screenings since 1990) and dietary data
(optional MONICA study, screenings since 1986) as a part of the National Environmental
Biobank. The participation rates have been 69-81%.
A separate registration is expected for the basic MONICA study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|